MediPharm Labs Corp.
MEDIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 26.9% | 49.5% | 1.9% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 30.5% | 17.7% | -8.7% | -70.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -17.9% | -31.7% | -115% | -177.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -25.5% | -39.6% | -135.6% | -252.4% |
| EPS Diluted | -0.026 | -0.036 | -0.11 | -0.22 |
| % Growth | 27.2% | 67.3% | 50% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |